193 related articles for article (PubMed ID: 30099298)
1. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
Wang Y; Niu M; Yin S; Zhang F; Shi R
Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril.
Wang Y; An W; Zhang F; Niu M; Liu Y; Shi R
Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1135-1148. PubMed ID: 29935093
[TBL] [Abstract][Full Text] [Related]
3. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats.
Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z
Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine in angiotensin II-induced hypertension.
Sasser JM; Moningka NC; Cunningham MW; Croker B; Baylis C
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R740-6. PubMed ID: 20018820
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C.
Helle F; Hultström M; Skogstrand T; Palm F; Iversen BM
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F78-86. PubMed ID: 18945823
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
[TBL] [Abstract][Full Text] [Related]
9. Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin II-induced hypertension.
Sasser JM; Cunningham MW; Baylis C
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1355-62. PubMed ID: 25298524
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
11. Dietary capsaicin-mediated attenuation of hypertension in a rat model of renovascular hypertension.
Segawa Y; Hashimoto H; Maruyama S; Shintani M; Ohno H; Nakai Y; Osera T; Kurihara N
Clin Exp Hypertens; 2020 May; 42(4):352-359. PubMed ID: 31518162
[No Abstract] [Full Text] [Related]
12. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
Zhu ZD; Ye JM; Fu XM; Wang XC; Ye JY; Wu XR; Hua P; Liao YQ; Xuan W; Duan JL; Li WY; Fu H; Xia ZH; Zhang X
Int J Mol Med; 2019 Feb; 43(2):749-760. PubMed ID: 30569164
[TBL] [Abstract][Full Text] [Related]
13. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
14. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2.
Hasegawa K; Wakino S; Tatematsu S; Yoshioka K; Homma K; Sugano N; Kimoto M; Hayashi K; Itoh H
Circ Res; 2007 Jul; 101(2):e2-10. PubMed ID: 17601800
[TBL] [Abstract][Full Text] [Related]
15. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
Onozato ML; Tojo A; Leiper J; Fujita T; Palm F; Wilcox CS
Diabetes; 2008 Jan; 57(1):172-80. PubMed ID: 17909098
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
Garbin U; Pasini AF; Stranieri C; Manfro S; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
Cheng MC; Wu TH; Huang LT; Tain YL
Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
[TBL] [Abstract][Full Text] [Related]
18. Sesamin exerts renoprotective effects by enhancing NO bioactivity in renovascular hypertensive rats fed with high-fat-sucrose diet.
Wu XQ; Kong X; Zhou Y; Huang K; Yang JR; Li XL
Eur J Pharmacol; 2012 May; 683(1-3):231-7. PubMed ID: 22314221
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S
J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
[TBL] [Abstract][Full Text] [Related]
20. The asymmetric dimethylarginine-mediated inhibition of nitric oxide in the rostral ventrolateral medulla contributes to regulation of blood pressure in hypertensive rats.
Tan X; Li JK; Sun JC; Jiao PL; Wang YK; Wu ZT; Liu B; Wang WZ
Nitric Oxide; 2017 Jul; 67():58-67. PubMed ID: 28392446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
